Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probe.

Terry J, Barry TS, Horsman DE, Hsu FD, Gown AM, Huntsman DG, Nielsen TO.

Diagn Mol Pathol. 2005 Jun;14(2):77-82.

PMID:
15905690
2.

Determination of stromal signatures in breast carcinoma.

West RB, Nuyten DS, Subramanian S, Nielsen TO, Corless CL, Rubin BP, Montgomery K, Zhu S, Patel R, Hernandez-Boussard T, Goldblum JR, Brown PO, van de Vijver M, van de Rijn M.

PLoS Biol. 2005 Jun;3(6):e187. Epub 2005 May 10.

3.

Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.

Nguyen TT, Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam Y.

Am J Surg Pathol. 2005 May;29(5):617-24.

PMID:
15832085
4.

Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans.

West RB, Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T, Montgomery K, Nielsen TO, Rubin BP, Patel R, Goldblum JR, Brown PO, van de Rijn M.

Am J Surg Pathol. 2004 Aug;28(8):1063-9. Erratum in: Am J Surg Pathol. 2004 Oct;28(10):1400. Chih Long, Lui [corrected to Chih Long, Liu].

PMID:
15252314
5.

The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.

West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, van de Rijn M.

Am J Pathol. 2004 Jul;165(1):107-13.

6.

A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.

Makretsov N, He M, Hayes M, Chia S, Horsman DE, Sorensen PH, Huntsman DG.

Genes Chromosomes Cancer. 2004 Jun;40(2):152-7.

PMID:
15101049
7.

Regulation of myeloid development and function by colony stimulating factors.

Barreda DR, Hanington PC, Belosevic M.

Dev Comp Immunol. 2004 May 3;28(5):509-54. Review.

PMID:
15062647
8.

SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model.

Murray LJ, Abrams TJ, Long KR, Ngai TJ, Olson LM, Hong W, Keast PK, Brassard JA, O'Farrell AM, Cherrington JM, Pryer NK.

Clin Exp Metastasis. 2003;20(8):757-66.

PMID:
14713109
9.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S, Fletcher JA.

J Clin Oncol. 2003 Dec 1;21(23):4342-9.

PMID:
14645423
10.

Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.

Linn SC, West RB, Pollack JR, Zhu S, Hernandez-Boussard T, Nielsen TO, Rubin BP, Patel R, Goldblum JR, Siegmund D, Botstein D, Brown PO, Gilks CB, van de Rijn M.

Am J Pathol. 2003 Dec;163(6):2383-95.

11.

The protein kinase complement of the human genome.

Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S.

Science. 2002 Dec 6;298(5600):1912-34. Review.

PMID:
12471243
12.

Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors.

Nilsson M, Höglund M, Panagopoulos I, Sciot R, Dal Cin P, Debiec-Rychter M, Mertens F, Mandahl N.

Virchows Arch. 2002 Nov;441(5):475-80. Epub 2002 Apr 13.

PMID:
12447678
13.

Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.

Rubin BP, Schuetze SM, Eary JF, Norwood TH, Mirza S, Conrad EU, Bruckner JD.

J Clin Oncol. 2002 Sep 1;20(17):3586-91.

PMID:
12202658
14.

Molecular characterisation of soft tissue tumours: a gene expression study.

Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein D, van de Rijn M.

Lancet. 2002 Apr 13;359(9314):1301-7.

PMID:
11965276
15.

Significance analysis of microarrays applied to the ionizing radiation response.

Tusher VG, Tibshirani R, Chu G.

Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21. Epub 2001 Apr 17. Erratum in: Proc Natl Acad Sci U S A 2001 Aug 28;98(18):10515.

16.

Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.

Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ, Lydon NB.

J Pharmacol Exp Ther. 2000 Oct;295(1):139-45.

17.

Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the Chromosomes and Morphology (CHAMP) study group.

Sciot R, Rosai J, Dal Cin P, de Wever I, Fletcher CD, Mandahl N, Mertens F, Mitelman F, Rydholm A, Tallini G, van den Berghe H, Vanni R, Willén H.

Mod Pathol. 1999 Jun;12(6):576-9.

PMID:
10392632
18.

Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP.

Nat Med. 1998 Jul;4(7):844-7.

PMID:
9662379
19.

Landscaping the cancer terrain.

Kinzler KW, Vogelstein B.

Science. 1998 May 15;280(5366):1036-7. No abstract available.

PMID:
9616081
20.

Giant cell tumor of tendon sheath is a polyclonal cellular proliferation.

Vogrincic GS, O'Connell JX, Gilks CB.

Hum Pathol. 1997 Jul;28(7):815-9.

PMID:
9224750
Items per page

Supplemental Content

Write to the Help Desk